Company Profiles

driven by the PitchBook Platform

immatics biotechnologies

Description

Developer of immunotherapies and drugs against cancer. The company engages in research & development of anti-cancerous vaccines based on multiple tumor-associated peptides that help to activate the self-defense mechanisms of the human body.

2000

Founded

PRIVATE

Status

51-200

Employees

Series D

Latest Deal Type

$46.1M

Latest Deal Amount

$186M

Total Amount Raised

Description

Developer of immunotherapies and drugs against cancer. The company engages in research & development of anti-cancerous vaccines based on multiple tumor-associated peptides that help to activate the self-defense mechanisms of the human body.

Website:

www.immatics.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

Paul-Ehrlich-Strasse 15 72076 TübingenGermany +49 (0)70 7153 970
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore immatics biotechnologies's full profile, request a free trial.

immatics biotechnologies Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

immatics biotechnologies Investors (18)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
3i GroupPE/BuyoutMinority000 0000000 0000
AT ImpfOtherMinority000 0000000 0000
b-to-v PartnersVenture CapitalMinority000 0000000 0000
Business Angels Stuttgart RegionAngel GroupMinority000 0000000 0000
DH CapitalInvestment BankMinority000 0000000 0000
3i Group PE/Buyout
AT Impf Other
b-to-v Partners Venture Capital
Business Angels Stuttgart Region Angel Group
DH Capital Investment Bank

immatics biotechnologies Executive Team (12)

NameTitleBoard
Seat
Contact
Info
Harpreet Singh Ph.DCo-founder, Managing Director & Chief Scientific Officer
Carsten Reinhardt Ph.DManaging Director & Chief Medical Officer
Rainer Kramer Ph.DManaging Director & Chief Business Officer
Silvio RometschDirector, Information Technology
Norbert HilfDirector, Translational Development
Harpreet Singh Ph.D Co-founder, Managing Director & Chief Scientific Officer
Carsten Reinhardt Ph.D Managing Director & Chief Medical Officer
Rainer Kramer Ph.D Managing Director & Chief Business Officer
Silvio Rometsch Director, Information Technology
Norbert Hilf Director, Translational Development

immatics biotechnologies Board Members (6)

NameRepresentingRoleSinceContact
Info
Christof Hettich JDSelfBoard Member000 0000
Erich SchlickWellington PartnersBoard Member000 0000
Friedrich von Bohlen und Halbach Ph.Ddievini Hopp BioTechBoard Member000 0000
Harald Stock Ph.DSelfBoard Member000 0000
Matthias Kromayer Ph.DSelfBoard Member000 0000
Christof Hettich JD Board Member Self
Erich Schlick Board Member Wellington Partners
Friedrich von Bohlen und Halbach Ph.D Board Member dievini Hopp BioTech
Harald Stock Ph.D Board Member Self
Matthias Kromayer Ph.D Board Member Self
Request full access to PitchBook